Orla Brennan

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

ViroXis Corp. develops and commercializes bio-pharmaceuticals derived from sandalwood oils for viral diseases. The company was founded in 2006 by Ian William David Clements and Paul Castella and is headquartered in San Antonio, TX.

Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY.

Part of Abbott Laboratories, Abbott Vascular Devices develops and manufactures cardiovascular devices for people with cardiovascular disease. The company is based in Redwood City, CA.

MedNova Ltd. manufactures medical devices. The company specializes in the development of minimally-invasive vascular products for the protection and repair of the heart, brain and blood vessels. It was founded in 1996 and is headquartered in Galway, Ireland.

Pasadera Capital LLC provides financial advisory services. It provides mezzanine and convertible debt financing, capital structuring, bankruptcy, private placements, recapitalizations, business turnaround, and mergers and acquisitions advisory services. The company is headquartered in San Antonio, TX.

Innovative Trauma Care, Inc. develops and markets medical devices for traumatic injuries. It is an early stage medical device company focused on developing and marketing solutions to address the common causes of preventable death in traumatic injury scenarios. The firm's product iTClamp Hemorrhage Control System is a temporary wound closure device to control severe bleeding within seconds of application to a penetrating injury. Its product iTClamp seals the edges of a wound closed to create a temporary pool of blood under pressure, which forms a stable clot that mitigates further blood loss until the wound can be surgically repaired. The company was founded by Ian Joseph Atkinson and Dennis Frank Filips in 2010 and is headquartered in San Antonio, TX.